First AD

Second AD

Hematologic Oncology

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Management of Myelodysplastic Syndromes in High-Risk Patients

Insights

Drs Madanat and Sekeres comment on the various risk stratification factors and prognostic criteria used in the classification of MDS disease.

Clinical Considerations in the Diagnosis of MDS

Classification of Myelodysplastic Syndrome

MDS: Risk Assessment Tools

High-Risk MDS: Prognostic and Predictive Factors

Clinical Implications of High-Risk MDS

High-Risk MDS: Clinical Efficacy Data

MDS Treatment-Related Toxicity and AEs

MDS Treatment: Patient Considerations

MDS: Clinical Primary Endpoints

Unmet Needs in MDS

MDS Treatment Selection: Impact of QoL

Future Directions in MDS